U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940881) titled 'A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors' on Nov. 10.

Brief Summary: The objective of the study is to evaluate the safety and tolerability of SI-B037 in participants with locally advanced or metastatic solid tumors.

Study Start Date: Aug. 24

Study Type: INTERVENTIONAL

Condition: Locally Advanced /Metastatic Solid Tumors Locally Advanced / Metastatic Solid Tumors First in Human Metastatic Solid Cancers Non Small Cell Lung Cancer NSCLC Lung Cancer (Diagnosis) Lung Cancer (NSCLC) Lung Cancer (Non-Small Cell) Lung Cancer (Locally Advan...